Old drugs, new tricks: the cancer drugs no one is willing to pay to test
Maisie Pollard discusses how drug repurposing could be used to discover cancer treatments, as well as the barriers to this research.
Maisie Pollard discusses how drug repurposing could be used to discover cancer treatments, as well as the barriers to this research.
Fin Spragg delves into the evolutionary history and biochemistry of carnivorous plants, linking them to the adaptation of plant immunity.
Louise Martin discusses the integration of AI into drug discovery and the legalities of patenting AI-designed drugs.
Louise Martin explores the promise and pitfalls of the weight-loss drugs taking the world by storm, weighing benefits against hidden costs.
Jemima explores how probabilistic modelling could help ships navigate rogue waves, which while rare and dangerous are now more predictable.
Elise Wilkinson explores the rise of AI and its implications on safety, economics, and human health overall.
Eva Knightley explores how ageing reshapes the immune system and the emerging therapies that could help extend healthy life.
Aury Mosseri examines the growing evidence linking fashion to environmental contamination and potential health risks.
Hannah Hunt explores the global pursuit of element 119, and how political tensions and scientific rivalry are redefining nuclear research.
Maisie Lambert explores how gender bias and biological differences contribute to the ADHD underdiagnosis in women and ensuing consequences.